Arkolith/Insider Trading/INDP/Form 4

Meckler Jeffrey A

Co-Chief Executive Officer, DirectorIndaptus Therapeutics, Inc. (INDP) · full profile →Form 4 · filed Feb 13, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 11, 2026Disposed to issuer(D)3K——0
Feb 11, 2026Grant(A)3K——3K
Feb 11, 2026Disposed to issuer(D)2K——0
Feb 11, 2026Grant(A)2K——2K
Feb 11, 2026Disposed to issuer(D)12K——0
Feb 11, 2026Grant(A)12K——12K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-006707) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML